Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
606.98B
Market cap606.98B
Price-Earnings ratio
61.83
Price-Earnings ratio61.83
Dividend yield
0.75%
Dividend yield0.75%
Average volume
6.55M
Average volume6.55M
High today
$760.00
High today$760.00
Low today
$633.20
Low today$633.20
Open price
$675.65
Open price$675.65
Volume
26.10M
Volume26.10M
52 Week high
$972.53
52 Week high$972.53
52 Week low
$633.20
52 Week low$633.20

LLY News

TipRanks 7h
Chugai Highlights Eli Lilly’s Positive Phase 3 Results for Orforglipron - TipRanks

...

Chugai Highlights Eli Lilly’s Positive Phase 3 Results for Orforglipron - TipRanks
Benzinga 13h
Apple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's Moving Markets Thursday?

U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove divergent moves in heavyweight name...

Apple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's Moving Markets Thursday?
CNBC 13h
We're downgrading Lilly and asking ourselves tough questions after its obesity pill letdown

Eli Lilly delivered strong second-quarter results on Thursday, but shares are plummeting because of disappointing data for a key late-stage trial. It's forcing...

We're downgrading Lilly and asking ourselves tough questions after its obesity pill letdown

Analyst ratings

80%

of 30 ratings
Buy
80%
Hold
13.3%
Sell
6.7%

More LLY News

Seeking Alpha 14h
Eli Lilly raises 2025 revenue guidance to $60B-$62B while expanding GLP-1 pipeline and production

Earnings Call Insights Eli Lilly raises 2025 revenue guidance to $60B-$62B while expanding GLP-1 pipeline and production Aug. 07, 2025 12:28 PM ET Eli Lilly and...

Eli Lilly raises 2025 revenue guidance to $60B-$62B while expanding GLP-1 pipeline and production
CNBC 19h
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

The Eli Lilly logo is shown on one of the company's offices in San Diego, California, on Sept. 17, 2020. Eli Lilly on Thursday hiked its 2025 guidance and post...

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
CNBC 20h
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval

Key Points Eli Lilly said the highest dose of its daily obesity pill helped patients lose more than 12% of their body weight, or roughly 27 pounds, at 72 weeks...

Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Seeking Alpha 2d
Can Eli Lilly keep its GLP-1 crown? Q2 earnings will tell

Eli Lilly (NYSE:LLY) is set to report Q2 earnings on Thursday, August 7, before the market opens, with Wall Street closely watching momentum around its blockbus...

Can Eli Lilly keep its GLP-1 crown? Q2 earnings will tell

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
Novo Nordisk
Broadcom
Meta Platforms
Costco
Microsoft
Taiwan Semiconductor Manu…
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.